These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26291980)

  • 1. Impact of Laboratory Practices on Interlaboratory Variability in Therapeutic Drug Monitoring of Immunosuppressive Drugs.
    Christians U; Vinks AA; Langman LJ; Clarke W; Wallemacq P; van Gelder T; Renjen V; Marquet P; Meyer EJ
    Ther Drug Monit; 2015 Dec; 37(6):718-24. PubMed ID: 26291980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results From a Proficiency Testing Pilot for Immunosuppressant Microsampling Assays.
    Veenhof H; Koster RA; Junier LAT; Zweipfenning P; Touw DJ
    Ther Drug Monit; 2023 Feb; 45(1):61-68. PubMed ID: 35971674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of LC-MS for therapeutic drug monitoring of tacrolimus.
    Annesley TM; McKeown DA; Holt DW; Mussell C; Champarnaud E; Harter L; Calton LJ; Mason DS
    Clin Chem; 2013 Nov; 59(11):1630-7. PubMed ID: 23902823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant.
    Aucella F; Lauriola V; Vecchione G; Tiscia GL; Grandone E
    J Pharm Biomed Anal; 2013 Dec; 86():123-6. PubMed ID: 23995754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
    Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
    Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants.
    Yang Z; Wang S
    J Immunol Methods; 2008 Jul; 336(2):98-103. PubMed ID: 18547583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive Drug Measurement by Liquid Chromatography Coupled to Tandem Mass Spectrometry: Interlaboratory Comparison in the Korean Clinical Laboratories.
    Kim HK; Park HD; Lee SG; Chae H; Song SH; Lee YW; Yun YM; Ahn S; Kim S; Lee SM; Lee SY; Chun S;
    Ann Lab Med; 2021 May; 41(3):268-276. PubMed ID: 33303711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients.
    Andrews LM; Riva N; de Winter BC; Hesselink DA; de Wildt SN; Cransberg K; van Gelder T
    Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):921-36. PubMed ID: 25865963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service.
    Pohanka A; Rosenborg S; Lindh JD; Beck O
    Clin Biochem; 2016 Sep; 49(13-14):1024-31. PubMed ID: 27372284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of psychotropic drugs in China: a nationwide survey.
    Guo W; Guo GX; Sun C; Zhang J; Rong Z; He J; Sun ZL; Yan F; Tang YL; Wang CY; Li WB
    Ther Drug Monit; 2013 Dec; 35(6):816-22. PubMed ID: 24263641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Performance of Laboratory-Developed Liquid Chromatography-Tandem Mass Spectrometry Tests and a Food and Drug Administration-Approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus.
    Schniedewind B; Meyer EJ; Christians U
    Ther Drug Monit; 2020 Jun; 42(3):421-426. PubMed ID: 32427781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.
    Taylor PJ; Tai CH; Franklin ME; Pillans PI
    Clin Biochem; 2011 Jan; 44(1):14-20. PubMed ID: 20599871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry.
    Peake RW; Hartigan CR; Esposito CL; Kellogg MD; Gabler J; Wang S; Breaud A; Di Bussolo J; Moskowitz J; Clarke W
    Ther Drug Monit; 2015 Apr; 37(2):161-71. PubMed ID: 25072947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Drug Monitoring of Everolimus: A Consensus Report.
    Shipkova M; Hesselink DA; Holt DW; Billaud EM; van Gelder T; Kunicki PK; Brunet M; Budde K; Barten MJ; De Simone P; Wieland E; López OM; Masuda S; Seger C; Picard N; Oellerich M; Langman LJ; Wallemacq P; Morris RG; Thompson C; Marquet P
    Ther Drug Monit; 2016 Apr; 38(2):143-69. PubMed ID: 26982492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedure for determination of immunosuppressive drugs in whole blood with liquid chromatography-isotope dilution mass spectrometry.
    Molnár PM; Dux L; Reinauer H; Kress M; Akerboom T; Szederkényi E; Kaiser P
    Clin Lab; 2011; 57(11-12):983-92. PubMed ID: 22239031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of immunosuppressants by liquid chromatography-mass spectrometry.
    McShane AJ; Bunch DR; Wang S
    Clin Chim Acta; 2016 Feb; 454():1-5. PubMed ID: 26721314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin monitoring in Australasia: survey of laboratory practices in 2000.
    Morris RG; Lam AK
    Ther Drug Monit; 2002 Aug; 24(4):471-8. PubMed ID: 12142629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel commercial assay for the determination of cyclosporine A, tacrolimus, sirolimus, and everolimus by liquid chromatography-tandem mass spectrometric assay.
    Becker S; Thiery J; Ceglarek U
    Ther Drug Monit; 2013 Feb; 35(1):129-32. PubMed ID: 23188181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.